Ascension Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Ascension Capital Advisors's AMGN Position: Q2 2026 in Review
Ascension Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 800 shares worth $290K. The position accounts for 0.08% of the portfolio, ranked #71.
Ascension Capital Advisors first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $449K in Q3 2023. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ascension Capital Advisors held 800 shares of Amgen worth $290K as of Q2 2026.
- Ascension Capital Advisors left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.08% of Ascension Capital Advisors's portfolio in Q2 2026, its #71 holding.
- Ascension Capital Advisors first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
- Ascension Capital Advisors's Amgen position peaked at $449K in Q3 2023.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ascension Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.